HealthMore in Health→
U.S. Drug Shortages Remain Systemic Despite 23% Decline, Analysis Warns
Key Takeaways
- U.S. drug shortages fell 23% last year but remain a systemic problem.
- Analysis shows prolonged shortages and unresolved supply chain vulnerabilities.
- Root causes include manufacturing quality issues and supplier concentration.
- Patients and providers face rationing and treatment delays.
DE
DT Editorial Team··via statnews.com